A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People
Status:
RECRUITING
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The study is a Phase I, randomized double-blind, placebo-controlled, single and multiple dosing, dose-escalation study of the oral administration of DDN-A-0101 in healthy adults and elderly subjects